Arbutus Biopharma
ABUS
#7159
Rank
S$0.80 B
Marketcap
S$5.27
Share price
1.49%
Change (1 day)
-10.68%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2026 (TTM): S$1.05

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is S$1.06. In 2025 the company made an earnings per share (EPS) of S-$0.22 an increase over its 2024 EPS that were of S-$0.49.

EPS history for Arbutus Biopharma from 1998 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$1.05-580.93%
2025S-$0.22-55.26%
2024S-$0.49-13.64%
2023S-$0.57-4.35%
2022S-$0.59-44.58%
2021S-$1.07-17%
2020S-$1.29-65.4%
2019S-$3.72138.84%
2018S-$1.56-22.44%
2017S-$2.01-78.45%
2016S-$9.32424.64%
2015S-$1.78-20.19%
2014S-$2.2387.96%
2013S-$1.18-142.59%
2012S$2.78-342.7%
2011S-$1.15-25.82%
2010S-$1.5447.8%
2009S-$1.05-43.55%
2008S-$1.85158.91%
2007S-$0.71-111.88%
2006S$6.02-552.53%
2005S-$1.33-71.77%
2004S-$4.71-14.48%
2003S-$5.51-8.95%
2002S-$6.0570.07%
2001S-$3.5648.01%
2000S-$2.40-38.54%
1999S-$3.91-24.6%
1998S-$5.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
S-$0.07724-107.32% Bahamas
NRC Health
NRC
S$0.37-64.63%๐Ÿ‡บ๐Ÿ‡ธ USA